Target
Histone deacetylase 1
1 abstract
Abstract
Quality-of-life measurement in high-risk patients with uveal melanoma receiving adjuvant sunitinib or valproic acid.Org: Thomas Jefferson University, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Sidney Kimmel Cancer Center at Thomas Jefferson University,